Leaders in Health Economics and Outcomes Research Convened to Focus on Improving Healthcare Systems

Published Nov 15, 2018

ISPOR Europe 2018 Drew the Society’s Largest Audience To Date With More Than 5000 Healthcare Stakeholders in Barcelona, Spain

Barcelona, Spain—November 15, 2018—ISPOR Europe 2018 concluded yesterday in Barcelona, Spain with record attendance. The Society had 5507 total attendees register for the event—the largest for any of its conferences to date. ISPOR Europe is organized by ISPOR—the professional society for health economics and outcomes research (HEOR)—and is the leading HEOR conference in the region. ISPOR Europe 2018 attendees include a wide variety of healthcare stakeholders, including researchers and academicians, assessors and regulators, payers and policy makers, the life sciences industry, and patient engagement organizations. The conference theme centered on “New Perspectives for Improving 21st Century Health Systems.” Program co-chairs included Sarah Garner, PhD, World Health Organization, Switzerland; Zoltán Kaló, PhD, Eötvös Loránd University, Hungary; and Guillem López-Casasnovas, PhD, Universitat Pompeu Fabra, Spain. Highlights from the ISPOR Europe 2018 program included: Plenary 1: Joint Assessment of Relative Effectiveness: ‘Trick or Treat’ for Decision Makers in EU Member States”This session was held on Monday, 12 November 2018 and the panel discussed the European Commission’s draft regulation on health technology assessment (HTA) that proposes the introduction of a Europe-wide joint clinical assessment. Plenary 2:Pharmaceutical Pricing: The Many Faces of FairnessThis session was held on Tuesday, 13 November 2018 with the panel focused on defining “fair” in the context of pharmaceutical pricing in the context of the World Health Organization’s first Fair Pricing Forum held in 2017. Plenary 3: Budget Impact and Expenditure Caps: Potential or Pitfall? This session was held Wednesday, 14 November 2018 and featured discussions on the benefits and challenges of controlling the budget impact of health policies by implementing financial caps in Europe. ISPOR Europe 2018 also featured sessions on artificial intelligence in healthcare, creating the “next” healthcare system, medical devices and European Union policy, pricing approaches and universal health coverage, how patient engagement is transforming healthcare, how a healthcare “cure” can be valued, ISPOR’s HEOR Competencies Framework™, and challenges to open science in HEOR. A number of awards were presented at the conference, including the Society’s Outstanding Chapter Awards. The conference also featured the Society’s renowned Essential HEOR Education curriculum of half- and full-day short courses on 10-11 November 2018. “HEOR has never been more important and the fact that ISPOR Europe 2018 drew the Society’s largest audience to date speaks to the significance of our members’ work,” stated ISPOR CEO Nancy S. Berg. “This conference focused on convening world leaders in health economics and outcomes research to discuss how to best improve health systems globally. ISPOR is honored to provide a forum for these important discussions and to play a role in improving healthcare decisions globally.” Additional information on ISPOR Europe 2018 can be found here. Released presentations from the conference can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORBarcelona.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.

ISPOR Launches “HEOR Explained” Microsite

Dec 10, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it has launched a new microsite—HEOR Explained—designed to help people better understand how health economics and outcomes research (HEOR) can improve healthcare decisions.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×